Recombinant Human Parathyroid Hormone Biocomposite Promotes Bone-to-Tendon Interface Healing by Enhancing Tenogenesis, Chondrogenesis, and Osteogenesis in a Rabbit Model of Chronic Rotator Cuff Tears
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY40(4) · pp.1093 · 2024
- 피인용
- Web of Science 16Scopus 14
- FWCI (Scopus)
- 2.84
- JCR IF
- JCR 2023 4.4
- ISSN
- 0749-8063
저자
- Han, Jian제1저자Huzhou Univ, Peoples Hosp Huzhou 1, Dept Orthopaed Surg, Affiliated Hosp 1, Huzhou, Zhejiang, Peoples R China
- Han, Sheng ChenSeoul Natl Univ, Bundang Hosp, Dept Orthopaed Surg, Coll Med, Seongnam, South Korea
- Jeong, Hyeon JangSeoul Natl Univ, Bundang Hosp, Dept Orthopaed Surg, Coll Med, Seongnam, South Korea
- Rhee, Sung MinKyung Hee Univ, Dept Orthoped Surg, Med Ctr, Seoul, South Korea
- 김영서Pusan Natl Univ, Sch Mech Engn, Busan, South Korea
- Jin, Yong JunAjou Univ, Sch Med, Dept Orthoped Surg, Suwon, South Korea
- 박석희Pusan Natl Univ, Sch Mech Engn, Busan, South Korea
- Oh, Joo Han교신저자Seoul Natl Univ, Bundang Hosp, Dept Orthopaed Surg, Coll Med, Seongnam, South Korea
초록
Purpose: To investigate the effect of recombinant human parathyroid hormone (rhPTH) biocomposite on bone-to-tendon interface (BTI) healing for surgical repair of a chronic rotator cuff tear (RCT) model of rabbit, focusing on genetic, histologic, biomechanical and micro–computed tomography (CT) evaluations. Methods: Sixty-four rabbits were equally assigned to the 4 groups: saline injection (group A), nanofiber sheet alone (group B), rhPTH-soaked nanofiber sheet (nanofiber sheet was soaked with rhPTH, group C), and rhPTH biocomposite (rhPTH permeated the nanofiber sheet by coaxial electrospinning, group D). The release kinetics of rhPTH (groups C and D) was examined for 6 weeks in vitro. Nanofiber scaffolds were implanted on the surface of the repair site 6 weeks after the induction of chronic RCT. Genetic and histologic analyses were conducted 4 weeks after surgery. Furthermore, genetic, histologic, biomechanical, micro-CT, and serologic analyses were performed 12 weeks after surgery. Results: In vivo, group D showed the highest collagen type I alpha 1 (COL1A1), collagen type III alpha 1 (COL3A1), and bone morphogenetic protein 2 (BMP-2) messenger RNA (mRNA) expression levels (all P < .001) 4 weeks after surgery; however, there were no differences between groups at 12 weeks postsurgery. After 12 weeks postsurgery, group D showed better collagen fiber continuity and orientation, denser collagen fibers, more mature bone-to-tendon junction, and greater fibrocartilage layer formation compared with the other groups (all P < .05). Furthermore, group D showed the highest load-to-failure rate (28.9 ± 2.0 N/kg for group A, 30.1 ± 3.3 N/kg for group B, 39.7 ± 2.7 N/kg for group C, and 48.2 ± 4.5 N/kg for group D, P < .001) and micro-CT outcomes, including bone and tissue mineral density, and bone volume/total volume rate (all P < .001) at 12 weeks postsurgery. Conclusions: In comparison to rhPTH-soaked nanofiber sheet and the other control groups, rhPTH biocomposite effectively accelerated BTI healing by enhancing the mRNA expression levels of COL1A1, COL3A1, and BMP-2 at an early stage and achieving tenogenesis, chondrogenesis, and osteogenesis at 12 weeks after surgical repair of a chronic RCT model of rabbit. Clinical Relevance: The present study might be a transitional study to demonstrate the efficacy of rhPTH biocomposites on BTI healing for surgical repair of chronic RCTs as an adaptable polymer biomaterial in humans.
키워드
MECHANICAL STRENGTHCALLUS FORMATIONTISSUE-REPAIRSTEM-CELLSCAFFOLDSCOLLAGENTERIPARATIDEREGENERATIONENHANCEMENTSTRATEGIES
식별자
- Scopus EID
- 2-s2.0-85179818637
- WoS UID
- 001225721600001



로그인
연구물 목록으로